{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:30:52Z","timestamp":1788931852794,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Generalitat of Catalonia","award":["2021 SGR 01345"],"award-info":[{"award-number":["2021 SGR 01345"]}]},{"name":"Generalitat of Catalonia","award":["9F22\/015"],"award-info":[{"award-number":["9F22\/015"]}]},{"name":"Generalitat of Catalonia","award":["SIDIAP-18\/12"],"award-info":[{"award-number":["SIDIAP-18\/12"]}]},{"name":"Diputaci\u00f3 de Lleida","award":["2021 SGR 01345"],"award-info":[{"award-number":["2021 SGR 01345"]}]},{"name":"Diputaci\u00f3 de Lleida","award":["9F22\/015"],"award-info":[{"award-number":["9F22\/015"]}]},{"name":"Diputaci\u00f3 de Lleida","award":["SIDIAP-18\/12"],"award-info":[{"award-number":["SIDIAP-18\/12"]}]},{"name":"Sanofi Pasteur-AIFICC-CAMFiC","award":["2021 SGR 01345"],"award-info":[{"award-number":["2021 SGR 01345"]}]},{"name":"Sanofi Pasteur-AIFICC-CAMFiC","award":["9F22\/015"],"award-info":[{"award-number":["9F22\/015"]}]},{"name":"Sanofi Pasteur-AIFICC-CAMFiC","award":["SIDIAP-18\/12"],"award-info":[{"award-number":["SIDIAP-18\/12"]}]},{"name":"IDIAP Jordi Gol","award":["2021 SGR 01345"],"award-info":[{"award-number":["2021 SGR 01345"]}]},{"name":"IDIAP Jordi Gol","award":["9F22\/015"],"award-info":[{"award-number":["9F22\/015"]}]},{"name":"IDIAP Jordi Gol","award":["SIDIAP-18\/12"],"award-info":[{"award-number":["SIDIAP-18\/12"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: The increasing global prevalence of inflammatory bowel disease (IBD) presents significant challenges to healthcare systems. Our objective was to identify the sociodemographic and clinical characteristics of IBD patients in Catalonia. Methods: A cross-sectional analytical study was carried out on patients diagnosed with IBD in Catalonia (2021). The database of the Information System for the Development of Research in Primary Care of Catalonia was used. Results: In Catalonia, the prevalence of IBD was 474 cases per 100,000 people (pcm), with an average diagnosis age of 42.9 years. Crohn\u2019s disease (CD) represented 34.34% of cases, and 21.2% were smokers and 1% were alcoholics. Nutritional status showed 3% underweight, 36.2% overweight, and 20% obese, with only 0.27% diagnosed as malnutrition. Mental health issues are notable; 36,531 pcm patients were diagnosed with anxiety and 14,656 pcm with depression, and 8.24% had a high risk of mortality measured by the Charlson index. The most prevalent vaccine-preventable infections were influenza (19,356 pcm), herpes zoster (8099 pcm), and varicella zoster (6946 pcm), with 4.56% of patients requiring hospitalisation for one of these reasons and 32.8% of patients for IBD complications, with higher rates observed in cases of CD. Conclusions: The prevalence of IBD was high, especially in urban areas, and patients showed a relevant number of comorbidities. IBD requires a comprehensive evaluation and interdisciplinary management to improve disease control.<\/jats:p>","DOI":"10.3390\/jcm13216476","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:29:57Z","timestamp":1730183397000},"page":"6476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Sociodemographic and Clinical Characteristics of Inflammatory Bowel Disease in Catalonia Based on SIDIAP"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-0447","authenticated-orcid":false,"given":"Cristina","family":"Garc\u00eda-Serrano","sequence":"first","affiliation":[{"name":"Catalan Health Institute (ICS), Primary Care, 25007 Lleida, Spain"},{"name":"Multidisciplinary Research Group on Therapeutics and Interventions in Primary Care (RETICAP Group), Fundaci\u00f3 Institut Universitari per a la Recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Mirada","sequence":"additional","affiliation":[{"name":"Faculty of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain"},{"name":"Public Health Agency of Catalonia, 08005 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepi","family":"Estany","sequence":"additional","affiliation":[{"name":"Catalan Health Institute (ICS), Primary Care, 25007 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-8958","authenticated-orcid":false,"given":"Joaquim","family":"Sol","sequence":"additional","affiliation":[{"name":"Catalan Health Institute (ICS), Primary Care, 25007 Lleida, Spain"},{"name":"Lleida Research Support Unit (USR), Fundaci\u00f3 Institut Universitari d\u2019Investigaci\u00f3 per a la Recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol), Rambla Ferran, 44, 25007 Lleida, Spain"},{"name":"Department of Experimental Medicine, University of Lleida-Lleida Biomedical Research Institute (UdL-IRBLleida), 25198 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-6841","authenticated-orcid":false,"given":"Marta","family":"Ortega-Bravo","sequence":"additional","affiliation":[{"name":"Catalan Health Institute (ICS), Primary Care, 25007 Lleida, Spain"},{"name":"Multidisciplinary Research Group on Therapeutics and Interventions in Primary Care (RETICAP Group), Fundaci\u00f3 Institut Universitari per a la Recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 Barcelona, Spain"},{"name":"Faculty of Medicine, University of Lleida, Pl. de V\u00edctor Siurana, 1, 25003 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5756-696X","authenticated-orcid":false,"given":"Eva","family":"Artigues-Barber\u00e0","sequence":"additional","affiliation":[{"name":"Catalan Health Institute (ICS), Primary Care, 25007 Lleida, Spain"},{"name":"Multidisciplinary Research Group on Therapeutics and Interventions in Primary Care (RETICAP Group), Fundaci\u00f3 Institut Universitari per a la Recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 Barcelona, Spain"},{"name":"Faculty of Nursing and Physiotherapy, University of Lleida, 25198 Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"ref_1","unstructured":"Oltra, L., and Casellas, F. (2016). Enfermedad Inflamatoria Intestinal para Enfermer\u00eda [Inflammatory Bowel Disease for Nursing], Elsevier. Available online: https:\/\/www.geteii.com\/wp-content\/uploads\/2017\/10\/Monografi\u00eda-EII-enfermeri\u00eda.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.gastrohep.2022.10.023","article-title":"Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn\u2019s Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease","volume":"46","author":"Ginard","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-018-0621-1","article-title":"Health Maintenance in Inflammatory Bowel Disease","volume":"20","author":"Mir","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ecco-jcc\/jjy020","article-title":"Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn\u2019s Disease or Ulcerative Colitis","volume":"12","author":"Kemp","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: From 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2020","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/jcag\/gwad004","article-title":"The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD, Journal of the Canadian Association of Gastroenterology","volume":"6","author":"Coward","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_13","first-page":"e201903013","article-title":"La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en Espa\u00f1a [Prevalence of ten immune-mediatedinflammatorydiseases (IMIDs) in Spain]","volume":"93","author":"Puig","year":"2019","journal-title":"Rev. Esp. Salud P\u00fablica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.crohns.2014.06.004","article-title":"Incidencia y evoluci\u00f3n inicial de las enfermedades inflamatorias intestinales en 2011 en Europa y Australia: Resultados del inicio de ECCO-EpiCom en 2011 cohorte","volume":"8","author":"Vegh","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chaparro, M., Garre, A., N\u00fa\u00f1ez Ortiz, A., Diz-Lois Palomares, M.T., Rodr\u00edguez, C., Riestra, S., Vela, M., Ben\u00edtez, J.M., Fern\u00e1ndez Salgado, E., and S\u00e1nchez Rodr\u00edguez, E. (2021). Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132885"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1093\/ije\/dyac068","article-title":"Data Resource Profile: The Information System for Research in Primary Care (SIDIAP)","volume":"51","author":"Recalde","year":"2022","journal-title":"Int. J. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2017.208","article-title":"Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study","volume":"112","author":"Benchimol","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_18","first-page":"72","article-title":"Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease","volume":"15","author":"Vedamurthy","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Soon, I.S., Molodecky, N.A., Rabi, D.M., Ghali, W.A., Barkema, H.W., and Kaplan, G.G. (2012). The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-analysis. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-51"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ecco-jcc\/jjv238","article-title":"Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease","volume":"10","author":"Severs","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11938-021-00364-9","article-title":"Health Maintenance for Adult Patients with Inflammatory Bowel Disease","volume":"19","author":"Hashash","year":"2021","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"ref_23","unstructured":"INE (2024, September 10). Determinantes de Salud (Consumo de Tabaco, Exposici\u00f3n Pasiva al Humo de Tabaco, Alcohol, Problemas Medioambientales en la Vivienda). Available online: https:\/\/www.ine.es\/ss\/Satellite?param1=PYSDetalle&c=INESeccion_C&param3=1259924822888&p=1254735110672&pagename=ProductosYServicios%2FPYSLayout&cid=1259926698156&L=1#:~:text=Seg%C3%BAn%20la%20Encuesta%20Europea%20de%20Salud%20en%20Espa%C3%B1a%202020%2C%20un,7%25%20en%20las%20mujeres."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.14309\/ajg.0000000000000608","article-title":"Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases","volume":"115","author":"Rozich","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_25","first-page":"649","article-title":"Alcohol and narcotics use in inflammatory bowel disease","volume":"31","author":"Mantzouranis","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"112196","DOI":"10.1016\/j.bbr.2019.112196","article-title":"Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact","volume":"376","author":"Qamar","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Balestrieri, P., Ribolsi, M., Guarino, M.P.L., Emerenziani, S., Altomare, A., and Cicala, M. (2020). Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients, 12.","DOI":"10.3390\/nu12020372"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Valvano, M., Capannolo, A., Cesaro, N., Stefanelli, G., Fabiani, S., Frassino, S., Monaco, S., Magistroni, M., Viscido, A., and Latella, G. (2023). Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease. Nutrients, 15.","DOI":"10.3390\/nu15173824"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ibd\/izac102","article-title":"High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course","volume":"29","author":"Gold","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_30","first-page":"2304","article-title":"Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn\u2019s Disease","volume":"21","author":"Pringle","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","article-title":"Feagins. Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease","volume":"60","author":"Flores","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/MIB.0000000000000560","article-title":"Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease","volume":"21","author":"Seminerio","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/apt.16444","article-title":"Comorbidity before and after a diagnosis of inflammatory bowel disease","volume":"54","author":"Bernstein","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","article-title":"Depression and anxiety in inflammatory bowel disease: Epidemiology, mechanisms and treatment","volume":"19","author":"Bisgaard","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpsychores.2016.06.001","article-title":"Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review","volume":"87","author":"Neuendorf","year":"2016","journal-title":"J. Psychosom. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/MCG.0000000000001094","article-title":"Predictors of Suicidal Ideation Among IBD Outpatients","volume":"53","author":"Hashash","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_38","first-page":"92","article-title":"Psychological Factors Are Associated with Changes in the Health-related Quality of Life in Inflammatory Bowel Disease","volume":"20","author":"Ferreiro","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2019.02.044","article-title":"Comparative Risk of Serious Infections With Biologic and\/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"18","author":"Singh","year":"2020","journal-title":"J. Clin. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjz013","article-title":"Relevant Infections in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their Effects on Disease Mortality","volume":"13","author":"Zabana","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Caballos, C.A.M., Gabbiadini, R., Dal Buono, A., Quadarella, A., De Marco, A., Repici, A., Bezzio, C., Simoneta, E., Aliberti, S., and Armuzzi, A. (2023). Participaci\u00f3n pulmonar en las enfermedades inflamatorias del intestino: V\u00edas compartidas y conexiones no deseadas. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196419"},{"key":"ref_46","unstructured":"Ministerio de Sanidad (2024, September 10). Vacunas y Programa de Vacunaci\u00f3n. Herpes Z\u00f3ster, Available online: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/vacunas\/ciudadanos\/zoster.htm."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Serrano, C., Artigues-Barber\u00e0, E., Mirada, G., Estany, P., Sol, J., and Ortega Bravo, M. (2023). Impact of an Intervention to Promote the Vaccination of Patients with Inflammatory Bowel Disease. Vaccines, 11.","DOI":"10.3390\/vaccines11111649"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Serrano, C., Mirada, G., Marsal, J.R., Ortega, M., Sol, J., Solano, R., Artigues, E.M., and Estany, P. (2020). Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: Implications on public health policies. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-08850-y"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Xu, F., Carlson, S.A., and Greenlund, K.J. (2024). Understanding primary care providers\u2019 attitudes towards preventive screenings to patients with inflammatory bowel disease. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0299890"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ecco-jcc\/jjaa023","article-title":"Quality of Care Standards in Inflammatory Bowel Diseases: A European Crohn\u2019s and Colitis Organisation [ECCO] Position Paper","volume":"14","author":"Fiorino","year":"2020","journal-title":"J. Crohn\u2019s Colitis"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:22:58Z","timestamp":1760113378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":51,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216476"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216476","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]}}}